Literature DB >> 3981767

The epidemiology of disease expenses. The costs of caring for children with cancer.

B S Bloom, R S Knorr, A E Evans.   

Abstract

We determined medical costs and family out-of-pocket expenses over time for 569 children with malignant neoplasms. All medical charges (inpatient and outpatient), family out-of-pocket expenses, and wages lost were collected and annualized. The mean cost of cancer care and treatment per patient-year was $29,708, with variation by diagnosis, prognosis, and year since diagnosis. The mean annual hospital inpatient cost was $15,455; mean ambulatory care cost, $3,806; and family out-of-pocket disease-related expenses, $9,787. Family out-of-pocket expenses added about 50% to the total cost of disease-related care and consumed 38% of gross annual family income; wages lost accounted for nearly half. About 95% of all medical costs was paid by private, public, or charitable payers. Out-of-pocket medical expenses for which the family was responsible were about $1,000 each year. However, all nonmedical, disease-related expenses were borne by the family.

Entities:  

Mesh:

Year:  1985        PMID: 3981767

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  23 in total

Review 1.  Economics of home intravenous services.

Authors:  N D Thickson
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

2.  Cost implications of wastage of drugs: focus on insulin.

Authors:  B Costa; M Belmonte
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 3.  Family caregiver costs of chronically ill and handicapped children: method and literature review.

Authors:  P Jacobs; S McDermott
Journal:  Public Health Rep       Date:  1989 Mar-Apr       Impact factor: 2.792

4.  A model for estimating the impact of changes in children's vaccines.

Authors:  K N Simpson; A K Biddle; N R Rabinovich
Journal:  Am J Public Health       Date:  1995-12       Impact factor: 9.308

5.  Economic burden of cancer in the United States: estimates, projections, and future research.

Authors:  K Robin Yabroff; Jennifer Lund; Deanna Kepka; Angela Mariotto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10       Impact factor: 4.254

Review 6.  Idarubicin: a pharmacoeconomic evaluation of its use in adult patients with acute myeloid leukaemia.

Authors:  R Whittington; K L Goa
Journal:  Pharmacoeconomics       Date:  1993-10       Impact factor: 4.981

7.  Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer.

Authors:  Veronica Dussel; Kira Bona; John A Heath; Joanne M Hilden; Jane C Weeks; Joanne Wolfe
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

8.  Social epidemiology: directions for the future in academic and "shoe-leather" risk analysis.

Authors:  J C Lane
Journal:  J Community Health       Date:  1987 Summer-Fall

Review 9.  The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.

Authors:  Nicolas Iragorri; Claire de Oliveira; Natalie Fitzgerald; Beverley Essue
Journal:  Curr Oncol       Date:  2021-03-15       Impact factor: 3.677

10.  Family life events in the first year of acute lymphoblastic leukemia therapy: a children's oncology group report.

Authors:  Samantha Lau; Xiaomin Lu; Lyn Balsamo; Meenakshi Devidas; Naomi Winick; Stephen P Hunger; William Carroll; Linda Stork; Kelly Maloney; Nina Kadan-Lottick
Journal:  Pediatr Blood Cancer       Date:  2014-08-30       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.